Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
addendum, Aexon, Aknin, Allouch, Allouche, Amyotrophic, Anthony, ASCP, Audrey, automating, Avista, Bachelor, Bassetti, Bern, bid, bioinnovation, biologist, biomanufacturing, bound, breadth, Bundesrat, Calcog, Caligor, career, CARF, CBM, CCPA, Chair, Chairwoman, Claudio, Clawback, Coghlan, compliant, CPA, creditor, CRO, cyber, Dean, degenerative, DEI, delete, diversifying, divestment, Docket, Eastern, Elena, email, endeavor, erosion, Erroneously, escalation, etiology, explain, Faculty, FDAFDA, Florence, fluctuate, Forecast, fundamental, Gallen, GBP, Greenberg, hearing, HEC, hereto, holistic, Huntington, inconsistent, Influential, Inselspital, insourcing, intrusion, ischemic, Israel, Ladle, Lausanne, Lumryz, magazine, mentor, Mercure, Miami, Microsoft, military, multinational, Myrpharm, neuro, Neurocenter, neurophysiology, nightly, online, overdue, Panel, Parkinson, penny, PepKon, Pharmacy, Philly, pinpointing, pioneered, Player, popular, post, professor, prompt, PRSA, Psychopharmacology, QDMTT, ready, refinancing, regain, renowned, rest, Revolutionary, routine, Russia, Schweizerische, shifting, Sorbonne, Southern, SOX, spanning, St, store, stored, stricter, studio, subcontractor, super, switching, tabletop, tech, theft, threat, Titan, Trailblazer, Tribune, unlock, version, viability, Walsh, Wharton, Woman, Women, Young
Removed:
Aalborg, AB, Assistant, biochemistry, built, cap, Catacap, CHEMM, ChemoMetec, computer, Copenhagen, Danish, Diagnostika, Directive, discussing, Econ, Friedrich, ImVisioN, Julier, Kwon, leased, leaving, LLP, Lokke, LUN, Lundbeck, Marcum, MGNX, Miescher, mitigate, MSc, Nextech, noticed, NUE, Nuevolution, observer, Pedersen, Planner, PMG, repay, sensitive, SSI, Stemform, Stig, subordinated, systemic, TAP, Telormedix, TRACON, unexpectedly, unnecessary, unsuccessful, USA, vulnerable
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.1 Description of Securities
- 4.17 Amendment No. 1 to Pre-funded Warrant Dated April 26, 2023 Between NLS Pharmaceutics LTD. and the Pre-funded Warrant Holders Named Therein
- 4.18 License Agreement by and Between NLS Pharmaceutics LTD. and Aexon Labs Inc., Dated March 19, 2024
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Pricewaterhousecoopers Ag.
- 16.1 Letter of Pricewaterhousecoopers Ag Dated May 15, 2024
- 97.1 Clawback Policy
- Download Excel data file
- View Excel data file
NLSP similar filings
Filing view
External links
Exhibit 13.2
CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350
In connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2023 (the “Report”) by NLS Pharmaceutics Ltd. (the “Company”), the undersigned, as Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, to my knowledge:
(1) | the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 15, 2024 | /s/ Elena Thyen-Pighin |
Elena Thyen-Pighin | |
Chief Financial Officer |